Chandran, Manju
Reginster, Jean-Yves
Kim, Mi-Young
Hiligsmann, Mickael https://orcid.org/0000-0003-4274-9258
Funding for this research was provided by:
Promedius
Article History
Received: 5 December 2025
Accepted: 13 January 2026
First Online: 21 January 2026
Declarations
:
: MC has received honoraria for speaking engagements from Kyowa Kirin and Amgen and travel grants from Amgen. JYR has received consultancy fees from and joined the Speakers Bureau for Echolight, Viatris, Theramex, Promedius and Besins. MC and JYR are Scientific Advisor Board members of Promedius. MYK is employee at Promedius Inc., Seoul, Republic of Korea. MH has received research grants (paid to institution) from Angelini Pharma, lecture fees from IBSA (paid to institution) and Echolight, and was grant advisor for Pfizer (paid to institution) and research advisor (paid to institution) for Grünenthal and for Teva. The funder had no access to the dataset and model, and had no role in study design, data collection or analysis.